CIAM
GPCR icon

Caitong International Asset Management’s Structure Therapeutics GPCR Stock Holding History

Caitong International Asset Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$537 Buy
+10
New +$442 ﹤0.01% 1712
2025
Q3 		– Sell
-835
Closed -$17.3K – 2171
2025
Q2 		$17.3K Buy
835
+459
+122% +$10.1K 0.01% 545
2025
Q1 		$6.51K Buy
376
+190
+102% +$4.65K ﹤0.01% 960
2024
Q4 		$5.04K Buy
+186
New +$6.6K ﹤0.01% 1043

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Caitong International Asset Management's GPCR Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 10 shares worth $537. The stake represents ﹤0.01% of the portfolio and ranks #1712 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in GPCR as recently as Q2 2025.

Caitong International Asset Management first reported a position in GPCR in Q4 2024 and has held it in 4 quarters since. The position peaked at $17.3K in Q2 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Caitong International Asset Management held 10 shares of Structure Therapeutics worth $537 as of Q2 2026.
  • Structure Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1712 holding.
  • Caitong International Asset Management first reported a position in Structure Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's Structure Therapeutics position peaked at $17.3K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.